Thermo Fisher Scientific (TMO) Q2 2023 Earnings Call Transcript

TMO earnings call for the period ending June 30, 2023.

Related Keywords

Rocky Mount ,North Carolina ,United States ,France ,Milan ,Lombardia ,Italy ,China ,American ,Chinese ,Matt Sykes ,Vijay Kumar Evercore ,Marc Casper ,Vijay Kumar ,Jack Meehan ,Rachel Vatnsdal Jpmorgan ,Stephen Williamson ,Gibco Oncopro Tumoroid ,Dan Arias ,Dan Brennan ,America Merrill Lynch ,Aaron Rodgers ,Matt Sykes Goldman Sachs ,Rachel Vatnsdal ,Rafael Tejada ,Jack Meehan Nephron Research Analyst ,American Society For Mass Spectrometry Conference ,Dan Arias Stifel Financial Corp ,Company Analyst ,Thermo Fisher ,Goldman Sachs ,Pfizer ,Nephron Research ,Derik De Bruin Bank ,Thermo Fisher Scientific ,Safe Harbor ,Private Securities Litigation Reform Act ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,American Society ,Mass Spectrometry Conference ,Scientific Orbitrap ,Astral Mass Spectrometer ,Orbitrap Astral ,Thermo Scientific Metrios ,Transmission Electron Microscope ,Gibco Oncopro Tumoroid Culture Medium ,Binding Site ,Latin America ,Middle East ,Vice President ,Chief Financial ,North America ,Investor Day ,Analyst Day ,Derik De Bruin ,Stifel Financial ,